Evidence map›Paper›PMID 40051732›Full record

ArticleIBRO neuroscience reports2025

Genetic variants of

Jolanta Dorszewska, Jolanta Florczak-Wyspiańska, Bartosz Słowikowski, Wojciech Owecki, Oliwia Szymanowicz, Ulyana Goutor, Mateusz Dezor, Paweł P Jagodziński, Wojciech Kozubski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IBRO neuroscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jolanta DorszewskaLaboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Jolanta Florczak-WyspiańskaChair and Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Bartosz SłowikowskiDepartment of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Poznan, Poland.
Wojciech OweckiLaboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Oliwia SzymanowiczLaboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Ulyana GoutorLaboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Mateusz DezorLaboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Paweł P JagodzińskiDepartment of Biochemistry and Molecular Biology, Poznan University of Medical Sciences, Poznan, Poland.
Wojciech KozubskiChair and Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of Parkinson's disease (PD) is influenced by a combination of genetic and environmental factors. Genetic variants of PARK2 (

Indexed as

Parkin, PINK1, ZNF746 proteinsParkinson’s diseaseZNF746 gene

Identifiers

PMID40051732
PMCPMC11883390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.